EMBLEM S-ICD
Report
- Report Number
- 2124215-2023-26718
- Event Type
- Injury
- Date Received
- May 26, 2023
- Date of Event
- June 1, 2015
- Report Date
- May 26, 2023
- Manufacturer
- BOSTON SCIENTIFIC CORPORATION
- Product Code
- LWS
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GM
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
NO ADDITIONAL INFORMATION IS AVAILABLE. IF ADDITIONAL INFORMATION BECOMES AVAILABLE, THE REPORT WILL BE UPDATED AT THAT TIME.
THIENEL, MANUELA, ET AL. (2022). "IMPAIRMENT OF QUALITY OF LIFE IN PATIENTS WITH IMPLANTED SUBCUTANEOUS CARDIOVERTER DEFIBRILLATOR (S-ICD) COMPARED TO IMPLANTED TRANSVENOUS CARDIOVERTER DEFIBRILLATOR THERAPY". PATIENT PREFERENCE AND ADHERENCE 2022:16 3027-3033. HTTPS://DOI.ORG/10.2147/PPA.S378741. IT WAS REPORTED IN A JOURNAL ARTICLE REVIEW OF 52 PATIENTS IMPLANTED WITH A SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (S-ICD) AND 52 PATIENTS IMPLANTED WITH A TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (TV-ICD), 27.7% OF S-ICD PATIENTS EXPECTED THEIR QUALITY OF LIFE TO IMPROVE BY EITHER DEACTIVATION OR EXPLANTATION OF THEIR DEVICE. BOTH S-ICD AND TV-ICD GROUPS REPORTED INAPPROPRIATE SHOCK (IAS) THERAPY, WITH A RATE OF 4.8 IAS PER PATIENT YEAR FOR THE S-ICD GROUP. PATIENTS REPORTED PAIN, MENTAL STRESS, AND FEAR AS A RESULT OF THEIR SHOCKS. PATIENT ALSO REPORTED DISCOMFORT AND PAIN FROM THE S-ICD POCKET ITSELF. OF NOTE, THE STUDY LOOKED AT PATIENT IMPLANTED WITH 2ND- OR 3RD-GENERATION S-ICD (BOSTON SCIENTIFIC SERIAL NUMBERS A209 AND A219). NO ADDITIONAL INFORMATION BESIDES THE JOURNAL ARTICLE IS AVAILABLE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1575965 | EMBLEM S-ICD | IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (NON-CRT) | LWS | BOSTON SCIENTIFIC CORPORATION |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Unknown | Other |